Literature DB >> 16164487

Achieving a sustained reduction in benzodiazepine use through implementation of an area-wide multi-strategic approach.

W B Dollman1, V T Leblanc, L Stevens, P J O'connor, E E Roughead, A L Gilbert.   

Abstract

OBJECTIVE: This study aimed to evaluate the impact, in a regional setting, of a multi-strategic partnership approach for reducing benzodiazepine use in the management of insomnia, as recommended in Australia's National Policy on Quality Use of Medicines.
METHOD: The setting was a rural region of South Australia, covering approximately 2000 km2, with a population of over 20 000. The study involved participatory action research, with qualitative and quantitative evaluations. The intervention involved a multi-strategic approach, including provision of treatment guidelines, provision of consumer information, a local media campaign and education and training of health professionals. The quantitative evaluation involved a single region before/after study with 2 years of follow-up using pharmacy-based dispensing data for benzodiazepines and antidepressants, gathered for the months of November to April in 1998/99 ('before' period) through to 2000/01 ('after' period). The data were analysed using non-parametric statistics.
RESULTS: There was a 19% reduction in benzodiazepine dispensing 2 years after the intervention compared with a 6% reduction nationally. Dispensing of antidepressants increased by 33%, compared with a 28% increase nationally.
CONCLUSION: It was concluded that the multi-strategic approach to the management of sleep disorders proved successful in promoting the use of non-drug alternatives, achieving sustained reduction in benzodiazepine consumption in a rural community, without therapeutic substitution of antidepressants. IMPLICATIONS: The study demonstrated that a sustainable reduction in prescribing of benzodiazepines can be achieved through the implementation of a multi-strategic approach involving local consumers, health professionals, a Division of General Practice, a government department, aged-care facilities and the local media.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16164487     DOI: 10.1111/j.1365-2710.2005.00674.x

Source DB:  PubMed          Journal:  J Clin Pharm Ther        ISSN: 0269-4727            Impact factor:   2.512


  14 in total

1.  How do different age groups use benzodiazepines and antidepressants? Analysis of an Australian administrative database, 2003-6.

Authors:  Alesha J Smith; Sue E Tett
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

Review 2.  Deprescribing Benzodiazepines in Older Patients: Impact of Interventions Targeting Physicians, Pharmacists, and Patients.

Authors:  Brendan J Ng; David G Le Couteur; Sarah N Hilmer
Journal:  Drugs Aging       Date:  2018-06       Impact factor: 3.923

Review 3.  Strategies to promote public engagement around deprescribing.

Authors:  Justin P Turner; Janet Currie; Johanna Trimble; Cara Tannenbaum
Journal:  Ther Adv Drug Saf       Date:  2018-09-12

Review 4.  Psychotropic drug-induced falls in older people: a review of interventions aimed at reducing the problem.

Authors:  Keith D Hill; Rohan Wee
Journal:  Drugs Aging       Date:  2012-01-01       Impact factor: 3.923

5.  Depression, Anxiety, and Patterns of Mental Health Care Among Men With Prostate Cancer Receiving Androgen Deprivation Therapy.

Authors:  Phoebe A Tsao; Ryan D Ross; Amy S B Bohnert; Bhramar Mukherjee; Megan E V Caram
Journal:  Oncologist       Date:  2022-04-05

Review 6.  Withdrawing benzodiazepines in primary care.

Authors:  Malcolm Lader; Andre Tylee; John Donoghue
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

Review 7.  Improving the use of benzodiazepines--is it possible? A non-systematic review of interventions tried in the last 20 years.

Authors:  Alesha J Smith; Susan E Tett
Journal:  BMC Health Serv Res       Date:  2010-11-30       Impact factor: 2.655

Review 8.  A systematic review of regulatory and educational interventions to reduce the burden associated with the prescriptions of sedative-hypnotics in adults treated for sleep disorders.

Authors:  Elsa Bourcier; Virginie Korb-Savoldelli; Gilles Hejblum; Christine Fernandez; Patrick Hindlet
Journal:  PLoS One       Date:  2018-01-22       Impact factor: 3.240

9.  Benzodiazepine Use among Medicare, Commercially Insured, and Veteran Older Adults, 2013-2017.

Authors:  Donovan T Maust; H Myra Kim; Ilse R Wiechers; Rosalinda V Ignacio; Amy S B Bohnert; Frederic C Blow
Journal:  J Am Geriatr Soc       Date:  2020-09-20       Impact factor: 5.562

10.  People with insomnia: experiences with sedative hypnotics and risk perception.

Authors:  Janet M Y Cheung; Delwyn J Bartlett; Carol L Armour; Jason G Ellis; Bandana Saini
Journal:  Health Expect       Date:  2015-08-03       Impact factor: 3.377

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.